JP2016210685A - Layered tablet - Google Patents

Layered tablet Download PDF

Info

Publication number
JP2016210685A
JP2016210685A JP2015092400A JP2015092400A JP2016210685A JP 2016210685 A JP2016210685 A JP 2016210685A JP 2015092400 A JP2015092400 A JP 2015092400A JP 2015092400 A JP2015092400 A JP 2015092400A JP 2016210685 A JP2016210685 A JP 2016210685A
Authority
JP
Japan
Prior art keywords
tablet
layer
unpleasant
intermediate layer
placenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015092400A
Other languages
Japanese (ja)
Inventor
博文 渡邉
Hirobumi Watanabe
博文 渡邉
明廣 杉山
Akihiro Sugiyama
明廣 杉山
森 淳
Atsushi Mori
淳 森
孝之 深澤
Takayuki Fukazawa
孝之 深澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP2015092400A priority Critical patent/JP2016210685A/en
Publication of JP2016210685A publication Critical patent/JP2016210685A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a tablet added with an active ingredient having at least one property of an unpleasant odor, an unpleasant taste and irritancy, the tablet allowing unpleasantness due to such a property to be inhibited in a convenient manner.SOLUTION: A layered tablet has an intermediate layer, which comprises an active ingredient having at least one property of an unpleasant odor, an unpleasant taste and irritancy, sandwiched by the top and bottom outer layers, and masks the property in an oral cavity.SELECTED DRAWING: None

Description

本発明は積層錠に関する。   The present invention relates to a laminated tablet.

一般に、不快臭、不快味若しくは刺激性等の性状を有する有効成分が添加された錠剤を、水又はお湯等で飲む場合、僅かの時間であっても口腔内での上記性状に起因する不快を感じる場合がある。   In general, when tablets with active ingredients having properties such as unpleasant odor, unpleasant taste or irritation are drunk with water or hot water, discomfort due to the above properties in the oral cavity even in a short time. You may feel it.

従来、上記のような性状による不快感を抑える錠剤として、特許文献1に記載の如くのものが提案されている。このような錠剤では、錠剤をフィルム若しくは糖衣によるコーティング、上記性状をもつ有効成分を硬化油、ワックス等による粉末コーティング、又はシクロデキストリンによる包接等を行なうことで、それらの性状をマスキングしている。   Conventionally, a tablet as described in Patent Document 1 has been proposed as a tablet for suppressing discomfort due to the above properties. In such tablets, the properties are masked by coating the tablets with a film or sugar coating, coating the active ingredients with the above properties with powder coating with hardened oil, wax or the like, or inclusion with cyclodextrins, etc. .

特開2012-036140号公報JP 2012-036140

従来の方法では、十分なマスキング効果がある一方、コーティング等の複雑な作業工程が必要になり、またそれに伴って錠剤サイズがスケールアップする問題も生じる。   While the conventional method has a sufficient masking effect, it requires a complicated work process such as coating, and accordingly, there is a problem that the tablet size is scaled up.

また、錠剤にフィルム或いは糖衣コーティングを行なうときには、コーティング中に生じる錠剤の割れ、欠けを防止するために、コーティングされる素錠に、ある一定以上の硬度をもたせ、摩損しにくくなるような製剤設計が必要になる。   In addition, when a film or sugar coating is applied to a tablet, the formulation is designed so that the coated uncoated tablet has a certain level of hardness and is not easily worn to prevent cracking or chipping of the tablet that occurs during coating. Is required.

また、錠剤にセラック等のコーティング剤を用いた場合には、崩壊遅延を起こさないような高度な膜厚制御が必要となる。   Further, when a coating agent such as shellac is used for the tablet, it is necessary to control the film thickness so as not to cause disintegration delay.

本発明の課題は、不快臭、不快味若しくは刺激性の少なくとも1つの性状を有する有効成分が添加された錠剤において、そのような性状による不快感を簡易に抑えることにある。   An object of the present invention is to easily suppress discomfort due to such properties in a tablet to which an active ingredient having at least one property of unpleasant odor, unpleasant taste or irritation is added.

請求項1に係る発明は、不快臭、不快味若しくは刺激性の少なくとも1つの性状を有する有効成分を含有する中間層を、上下の外層によって挟み、上記性状を口腔内でマスキングした積層錠である。   The invention according to claim 1 is a laminated tablet in which an intermediate layer containing an active ingredient having at least one property of unpleasant odor, unpleasant taste or irritation is sandwiched between upper and lower outer layers and the above properties are masked in the oral cavity. .

請求項2に係る発明は、請求項1に係る発明において更に、前記外層に香料と甘味料の少なくとも1種を含有したものである。   The invention according to claim 2 is the invention according to claim 1, wherein the outer layer further contains at least one of a fragrance and a sweetener.

請求項3に係る発明は、請求項1又は2に係る発明において更に、前記外層に前記性状を有しない有効成分を含有したものである。   The invention according to claim 3 is the invention according to claim 1 or 2, further comprising an active ingredient having no such property in the outer layer.

請求項4に係る発明は、請求項1〜3のいずれかに係る発明において更に、前記外層に中間層におけると同じ賦形剤を含有したものである。   The invention according to claim 4 is the invention according to any one of claims 1 to 3, wherein the outer layer further contains the same excipient as in the intermediate layer.

(請求項1)
(a)中間層に含有した有効成分がもつ不快臭、不快味若しくは刺激性の少なくとも1つの性状を、積層錠を構成する外層によってマスキングするものとした。コーティング等の複雑な作業工程が不要になり、常法による積層錠の製造工程で簡易に製造できるし、コーティングに伴う錠剤サイズのスケールアップの不都合も生じない。
(Claim 1)
(a) At least one property of unpleasant odor, unpleasant taste or irritation which the active ingredient contained in the intermediate layer has is masked by the outer layer constituting the laminated tablet. A complicated work process such as coating is not required, and it can be easily manufactured by a conventional manufacturing method of a laminated tablet, and there is no inconvenience of scale-up of the tablet size accompanying the coating.

尚、積層錠は、打錠機の臼に装填した下層材料を杵によって打錠して下層を形成し、次に該臼内の下層の上に装填した中間層材料を杵によって打錠して該下層の上に中間層を接着させて形成し、次に該臼内の中間層の上に装填した上層材料を杵によって打錠して該中間層の上に上層を接着させて形成し、1台の打錠機の連続する打錠操作によって簡易に全3層構造を作製可能にされる。   The laminated tablet is formed by pressing the lower layer material loaded in the die of the tableting machine with a punch to form the lower layer, and then pressing the intermediate layer material loaded on the lower layer in the die with the punch. Forming an intermediate layer on the lower layer, and then compressing the upper layer material loaded on the intermediate layer in the die with a punch to adhere the upper layer on the intermediate layer; A three-layer structure can be easily produced by a continuous tableting operation of one tableting machine.

(b)積層錠では、コーティングを不要としたことから、硬度の制限がない。また、素錠からなる積層錠では、セラック等のコーティング剤を用いた場合におけるような、崩壊遅延を生じるおそれもない。   (b) The laminated tablet is not limited in hardness because it does not require coating. In addition, a laminated tablet composed of uncoated tablets does not have a possibility of causing a disintegration delay as in the case of using a coating agent such as shellac.

(請求項2)
(c)外層に香料を含有することにより、不快臭はもちろん不快味に対してもマスキング効果を高めることができる。
(Claim 2)
(c) By containing a fragrance in the outer layer, the masking effect can be enhanced not only for unpleasant odors but also for unpleasant tastes.

(d)外層に甘味料を含有することにより、不快味はもちろん不快臭に対してもマスキング効果を高めることができる。   (d) By containing a sweetener in the outer layer, it is possible to enhance the masking effect against unpleasant taste as well as unpleasant odor.

(請求項3)
(e)不快臭、不快味又は刺激性等の性状を有しない有効成分であれば、外層に添加できる。
(Claim 3)
(e) Any active ingredient having no properties such as unpleasant odor, unpleasant taste or irritation can be added to the outer layer.

(請求項4)
(f)マスキング効果をもつ外層に中間層と同等の賦形剤等を利用することにより、外層と中間層の接着性の相性を良くし、製剤設計を簡易化できる。
(Claim 4)
(f) By using an excipient equivalent to the intermediate layer for the outer layer having a masking effect, the compatibility of the adhesion between the outer layer and the intermediate layer can be improved, and the formulation design can be simplified.

図1は不快臭の官能試験で使用したVASを示す説明図である。FIG. 1 is an explanatory diagram showing VAS used in a sensory test for unpleasant odor. 図2はプラセンタ錠の不快臭に対する官能評価結果を示すグラフである。FIG. 2 is a graph showing sensory evaluation results for an unpleasant odor of placenta tablets. 図3は不快味の官能試験で使用したVASを示す説明図である。FIG. 3 is an explanatory diagram showing the VAS used in the sensory test for unpleasant taste. 図4はプラセンタ錠の不快味に対する官能評価結果を示すグラフである。FIG. 4 is a graph showing sensory evaluation results for the unpleasant taste of placenta tablets. 図5はプラセンタ錠(香料あり)の不快味に対する官能評価結果を示すグラフである。FIG. 5 is a graph showing sensory evaluation results for the unpleasant taste of placenta tablets (with fragrance).

[実施例1]
プラセンタ積層錠の不快臭のマスキング効果
通常の単層錠A(9mmφ、300mg/錠)を対照とし、不快臭と不快味を有するプラセンタ末を配合した中間層を上下の外層によって挟んだ3層の積層錠B(9mmφ、300mg/錠)を常法により作製した。外層は不快臭、不快味又は刺激性を有する成分を含有していない。
[Example 1]
Masking effect of unpleasant odor of placenta layered tablets Three layers with an intermediate layer containing placenta powder with unpleasant odor and unpleasant taste sandwiched between the upper and lower outer layers, as a standard single layer tablet A (9mmφ, 300mg / tablet) Laminated tablet B (9 mmφ, 300 mg / tablet) was prepared by a conventional method. The outer layer does not contain components having an unpleasant odor, unpleasant taste or irritation.

積層錠Bは、表1に示した、外層(75mg×2)と中間層(150mg)の処方からなる。単層錠Aは、表1の外層(75mg×2)と中間層(150mg)の処方を全て混合して作製された。   The laminated tablet B is composed of an outer layer (75 mg × 2) and an intermediate layer (150 mg) as shown in Table 1. Monolayer tablet A was prepared by mixing all the formulations of the outer layer (75 mg × 2) and the intermediate layer (150 mg) in Table 1.

表1の外層と中間層の構成成分において、還元麦芽糖と結晶セルロースは賦形剤、ステアリン酸カルシウムは滑沢剤、微粒二酸化ケイ素は流動性改善剤として用いられたものである。外層は、中間層においてプラセンタ末を除いた成分と同成分を含有し、中間層におけると同じ賦形剤等を含有するものである。   In the constituents of the outer layer and the intermediate layer in Table 1, reduced maltose and crystalline cellulose were used as excipients, calcium stearate was used as a lubricant, and fine silicon dioxide was used as a fluidity improver. The outer layer contains the same components as the components excluding the placenta powder in the intermediate layer, and contains the same excipients and the like as in the intermediate layer.

Figure 2016210685
Figure 2016210685

単層錠Aと積層錠Bのプラセンタによる不快臭の差を比較するために、官能評価によるモニター試験を男女18名に対して行なった。官能評価方法として、図1に示すVAS(Visual Analog Scale)を用いて、プラセンタ錠(単層錠Aと積層錠B)を口腔内に入れたときに感じる不快臭について、「まったく気にならない」から「摂取し難いくらい気になる」の範囲において被験者が感じる地点にチェックを入れることにより検証した。   In order to compare the difference in unpleasant odor due to the placenta of single-layer tablet A and multilayer tablet B, a monitor test by sensory evaluation was conducted on 18 men and women. As a sensory evaluation method, VAS (Visual Analog Scale) shown in FIG. 1 is used, and the unpleasant odor felt when placing placenta tablets (single-layer tablet A and multilayer tablet B) in the oral cavity is “not at all concerned”. To “I am worried that it is difficult to ingest”.

プラセンタ錠(単層錠Aと積層錠B)の不快臭についての官能評価の結果を図2に示す。マスキング層(外層)を有する積層錠Bは、単層錠Aと比較して不快臭が50%程度軽減され、統計的に有意な差が示された。   The result of sensory evaluation about the unpleasant odor of the placenta tablet (single-layer tablet A and laminated tablet B) is shown in FIG. The laminated tablet B having a masking layer (outer layer) had an unpleasant odor reduced by about 50% compared to the single-layer tablet A, and a statistically significant difference was shown.

[実施例2]
プラセンタ積層錠の不快味のマスキング効果
実施例1で作製したと同じ単層錠Aと積層錠Bのプラセンタによる不快味の差を比較するために、図3に示すVASを用いて、プラセンタ錠(単層錠Aと積層錠B)を口腔内に入れたときに感じる不快味を実施例1におけると同様の官能評価方法で検証した。
[Example 2]
Masking effect of unpleasant taste of placenta laminated tablet In order to compare the difference in unpleasant taste of the same single layer tablet A and laminated tablet B produced by Example 1 with placenta, the placenta tablet ( The unpleasant taste felt when the monolayer tablet A and the multilayer tablet B) were put in the oral cavity was verified by the same sensory evaluation method as in Example 1.

プラセンタ錠(単層錠Aと積層錠B)の不快味についての官能評価の結果を図4に示す。マスキング層(外層)を有する積層錠Bは、単層錠Aと比較して不快味が38%程度軽減され、統計的に有意な差が示された。これは積層錠Bでは、口腔内で舌と中間層のプラセンタとの接触面積が低減されるため、不快味のマスキング効果が表れたものと考えられる。   The result of sensory evaluation about the unpleasant taste of the placenta tablet (single-layer tablet A and laminated tablet B) is shown in FIG. The layered tablet B having a masking layer (outer layer) had an unpleasant taste reduced by about 38% compared to the single layer tablet A, and showed a statistically significant difference. This is considered to be because the layered tablet B has a masking effect of unpleasant taste because the contact area between the tongue and the placenta of the intermediate layer is reduced in the oral cavity.

[実施例3]
外層に香料を添加したプラセンタ積層錠の不快味のマスキング効果
一般に、錠剤の不快臭をマスキングする方法として、錠剤に香料が添加される。そこで、香料を添加した単層錠C(9mmφ、300mg/錠)を対照とし、不快臭と不快味を有するプラセンタ末を配合した中間層を、香料が添加された上下の外層によって挟んだ3層の積層錠D(9mmφ、300mg/錠)を作製した。外層は不快臭、不快味又は刺激性を有する成分を含有していない。
[Example 3]
Masking effect of unpleasant taste of a placenta laminated tablet in which a fragrance is added to the outer layer Generally, a fragrance is added to a tablet as a method of masking an unpleasant odor of the tablet. Therefore, as a control, a single layer tablet C (9 mmφ, 300 mg / tablet) added with a fragrance, an intermediate layer containing a placenta powder having an unpleasant odor and an unpleasant taste sandwiched between upper and lower outer layers added with a fragrance A multilayer tablet D (9 mmφ, 300 mg / tablet) was prepared. The outer layer does not contain components having an unpleasant odor, unpleasant taste or irritation.

積層錠Dは、表2に示した、外層(75mg×2)と中間層(150mg)の処方からなる。単層錠Cは、表2の外層(75mg×2)と中間層(150mg)の処方を全て混合して作製された。   The laminated tablet D is composed of the formulation of the outer layer (75 mg × 2) and the intermediate layer (150 mg) shown in Table 2. Monolayer tablet C was prepared by mixing all the formulations of the outer layer (75 mg × 2) and the intermediate layer (150 mg) in Table 2.

表2の外層と中間層の構成成分において、還元麦芽糖と結晶セルロースは賦形剤、ステアリン酸カルシウムは滑沢剤、微粒二酸化ケイ素は流動性改善剤として用いられたものである。外層は、香料以外には中間層においてプラセンタ末を除いた成分と同成分を含有し、中間層におけると同じ賦形剤等を含有するものである。   In the constituents of the outer and intermediate layers in Table 2, reduced maltose and crystalline cellulose were used as excipients, calcium stearate was used as a lubricant, and fine silicon dioxide was used as a fluidity improver. The outer layer contains the same components as the components except the placenta powder in the intermediate layer other than the fragrance, and contains the same excipients and the like as in the intermediate layer.

Figure 2016210685
Figure 2016210685

香料が添加されたプラセンタ錠では、単層錠Cと積層錠Dのいずれにあっても、香料による消臭効果(不快臭マスキング効果)を得ることができ、単層錠Cと積層錠Dの不快臭についての有意な差は認められなかった。そこで、香料が添加された単層錠Cと積層錠Dプラセンタによる不快味の差を比較した。   In the placenta tablet to which the fragrance is added, the deodorizing effect (unpleasant odor masking effect) by the fragrance can be obtained in any of the single-layer tablet C and the laminated tablet D. There was no significant difference in unpleasant odor. Then, the difference in the unpleasant taste by the single layer tablet C to which the fragrance | flavor was added and the laminated tablet D placenta was compared.

即ち、香料が添加されたプラセンタ錠(単層錠Cと積層錠D)の不快味を、実施例2におけると同じVASを用いた官能評価方法で検証した。   That is, the unpleasant taste of the placenta tablets (single-layer tablet C and laminated tablet D) to which a fragrance was added was verified by the same sensory evaluation method using VAS as in Example 2.

プラセンタ錠(単層錠Cと積層錠D)の不快味についての官能評価の結果を図5に示す。単層錠Cは、香料が添加されたことによって、実施例2の単層錠Aに比較して不快味が低減されるものの、香料が添加されたマスキング層を外層に有する積層錠Dでは、その単層錠Cに対しても不快味が32%程度低減されるものになり、統計的に有意な差が示された。   The result of sensory evaluation about the unpleasant taste of the placenta tablet (single-layer tablet C and laminated tablet D) is shown in FIG. Although the unpleasant taste is reduced compared to the single layer tablet A of Example 2 due to the addition of the fragrance, the single layer tablet C is a laminated tablet D having a masking layer to which the fragrance is added in the outer layer. The unpleasant taste was also reduced by about 32% for the monolayer tablet C, and a statistically significant difference was shown.

[実施例4]
外層に有効成分を添加したプラセンタ積層錠の処方例
実施例1〜3では、マスキング層となる外層に有効成分が含有されていないが、不快臭、不快味又は刺激性等の性状を有しない有効成分であれば、外層に添加しても良い。実施例4の積層錠E(9mmφ、320mg/錠)は、常法により作製され、表3に示す如く、不快臭と不快味を有するプラセンタ末、サケ鼻軟骨抽出物等を配合した中間層を、コラーゲンとアスコルビン酸を有効成分として含有した上下の外層によって挟んだ3層構造をなす。尚、中間層に添加されたプラセンタ末、ハトムギエキス、エラスチン、サケ鼻軟骨抽出物、ブドウエキス、アスタキサンチンは、美容成分(有効成分)として配合された。
[Example 4]
Formulation example of a placenta laminated tablet with an active ingredient added to the outer layer In Examples 1 to 3, the active layer does not contain an active ingredient in the outer layer serving as a masking layer, but has no properties such as unpleasant odor, unpleasant taste or irritation If it is a component, it may be added to the outer layer. The laminated tablet E (9 mmφ, 320 mg / tablet) of Example 4 was prepared by a conventional method, and as shown in Table 3, an intermediate layer containing a placenta powder having an unpleasant odor and an unpleasant taste, salmon nasal cartilage extract and the like was blended. It has a three-layer structure sandwiched between upper and lower outer layers containing collagen and ascorbic acid as active ingredients. The placenta powder, pearl barley extract, elastin, salmon nasal cartilage extract, grape extract and astaxanthin added to the intermediate layer were blended as cosmetic ingredients (active ingredients).

積層錠Eは、表3に示した外層(85mg×2)と中間層(150mg)の外層からなる。
表3の外層と中間層の構成成分において、還元麦芽糖と結晶セルロースは賦形剤、ステアリン酸カルシウムは滑沢剤、微粒二酸化ケイ素は流動性改善剤として用いられたものである。外層は、香料及び上記の有効成分以外には、中間層においてプラセンタ末、サケ鼻軟骨抽出物等の美容成分(有効成分)を除いた成分と同成分を含有し、中間層におけると同じ賦形剤等を含有するものである。
The multilayer tablet E consists of an outer layer (85 mg × 2) and an intermediate layer (150 mg) shown in Table 3.
In the constituents of the outer and intermediate layers in Table 3, reduced maltose and crystalline cellulose were used as excipients, calcium stearate was used as a lubricant, and fine silicon dioxide was used as a fluidity improver. The outer layer contains the same ingredients as the ingredients other than the perfume and the above active ingredients, except for the beauty ingredients (active ingredients) such as placenta powder and salmon nasal cartilage extract in the intermediate layer, and the same shaping as in the intermediate layer Containing an agent and the like.

Figure 2016210685
Figure 2016210685

積層錠Eは、積層錠B、積層錠Dと同等のマスキング効果を有することが認められた。   It was confirmed that the laminated tablet E had the same masking effect as the laminated tablet B and the laminated tablet D.

以上、本発明の実施例を図面により詳述したが、本発明の具体的な構成はこの実施例に限られるものではなく、本発明の要旨を逸脱しない範囲の設計の変更等があっても本発明に含まれる。例えば、本発明の積層錠は、カプサイシン、胡椒エキス、生姜エキス等の刺激性の性状を有する有効成分を含有する中間層を、上下の外層によって挟むことにより、上記性状を口腔内でマスキングすることもできる。   The embodiment of the present invention has been described in detail with reference to the drawings. However, the specific configuration of the present invention is not limited to this embodiment, and even if there is a design change or the like without departing from the gist of the present invention. It is included in the present invention. For example, the laminated tablet of the present invention masks the above properties in the oral cavity by sandwiching an intermediate layer containing active ingredients having stimulating properties such as capsaicin, pepper extract, ginger extract, etc. between upper and lower outer layers. You can also.

本発明によれば、不快臭、不快味若しくは刺激性の少なくとも1つの性状を有する有効成分が添加された錠剤において、そのような性状による不快感を簡易に抑えることができる。   According to the present invention, in tablets to which an active ingredient having at least one property of unpleasant odor, unpleasant taste or irritation is added, discomfort due to such properties can be easily suppressed.

Claims (4)

不快臭、不快味若しくは刺激性の少なくとも1つの性状を有する有効成分を含有する中間層を、上下の外層によって挟み、上記性状を口腔内でマスキングすることを特徴とする積層錠。   A laminated tablet comprising an intermediate layer containing an active ingredient having at least one property of unpleasant odor, unpleasant taste or irritation, sandwiched between upper and lower outer layers and masking the property in the oral cavity. 前記外層に香料と甘味料の少なくとも1種を含有した請求項1に記載の積層錠。   The laminated tablet according to claim 1, wherein the outer layer contains at least one of a fragrance and a sweetener. 前記外層に前記性状を有しない有効成分を含有した請求項1又は2に記載の積層錠。   The laminated tablet according to claim 1 or 2, wherein the outer layer contains an active ingredient having no properties. 前記外層に中間層におけると同じ賦形剤を含有した請求項1〜3のいずれかに記載の積層錠。   The laminated tablet according to any one of claims 1 to 3, wherein the outer layer contains the same excipient as in the intermediate layer.
JP2015092400A 2015-04-28 2015-04-28 Layered tablet Pending JP2016210685A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015092400A JP2016210685A (en) 2015-04-28 2015-04-28 Layered tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015092400A JP2016210685A (en) 2015-04-28 2015-04-28 Layered tablet

Publications (1)

Publication Number Publication Date
JP2016210685A true JP2016210685A (en) 2016-12-15

Family

ID=57549235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015092400A Pending JP2016210685A (en) 2015-04-28 2015-04-28 Layered tablet

Country Status (1)

Country Link
JP (1) JP2016210685A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114712323A (en) * 2022-05-18 2022-07-08 贵州奇源生物制品有限公司 Human placenta tablet and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114712323A (en) * 2022-05-18 2022-07-08 贵州奇源生物制品有限公司 Human placenta tablet and preparation method thereof

Similar Documents

Publication Publication Date Title
MY153658A (en) Methods of making compositions comprising films
RS54398B1 (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
ATE543489T1 (en) ORAL DOSAGE FORMS CONTAINING PROGESTERONE AND METHODS OF USE AND MANUFACTURING THEREOF
PL1871181T3 (en) Nutritional supplement for hiv patients
TW200640486A (en) Composition
ATE488225T1 (en) CHEWABLE, SUCKABLE AND SWALLOWABLE TABLET WITH A CALCIUM CONTAINING COMPOUND AS THE ACTIVE INGREDIENT
Bansal et al. Comparative evaluation of effectiveness of three desensitizing tooth pastes for relief in the dentinal hypersensitivity
WO2005077343A3 (en) Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
PL1680128T3 (en) Myo-inositol hexaphosphate for topical use
CN103585072A (en) Composition for inhibiting body odor and tissue applying composition
MX2011011459A (en) Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders.
CN107864620A (en) Moschus composition and its application method
JPWO2008090736A1 (en) Medicament for the prevention and treatment of Alzheimer type dementia
JP2016210685A (en) Layered tablet
MX2017000047A (en) Anhydrous soft solid composition based on particles encapsulating a beneficial agent.
TW200518766A (en) Medicinal composition
ATE424896T1 (en) DEPIGMENTIZING OR WHITENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE AS AN ACTIVE INGREDIENT
WO2007037790A3 (en) Modified release famciclovir compositions
JP3193018U (en) Deodorant composition tablets
DE60107441D1 (en) USE OF A POLLEN EXTRACT-CONTAINING COMPOUND FOR TREATING DYSPHORIA
UA97355C2 (en) Pharmaceutical composition containing montelukast
JP2006282591A (en) Facial wash composition
JP6320874B2 (en) Method for producing edible metal foil
JP2016084306A (en) Effervescent tablet
CN104434543A (en) Provisional denture base and oral mucosa buffer material and manufacturing and using method